News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zhejiang Hisun Pharma Files for US Approval to Start Clinical Trial of Statin


4/9/2012 9:07:49 AM

April 6, 2012 -- Zhejiang Hisun Pharmaceutical, a China company with numerous cross-border relationships, has successfully filed an Investigational New Drug application with the FDA in the US to begin clinical trials of an innovative cholesterol-lowering statin. Frontage Labs, a, CRO with operations in China and the US, completed the work on behalf of Hisun. Earlier this year, Hisun announced a $545 million generic drug JV with Pfizer. More details....

Stock Symbols: (SHA: 600267) (NYSE: PFE)


Read at ChinaBio Today

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES